# Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]

> **NCT02300753** · — · NO_LONGER_AVAILABLE · sponsor: **Edison Pharmaceuticals Inc**

## Conditions studied

- Leber's Hereditary Optic Neuropathy

## Interventions

- **DRUG:** EPI-743

## Key facts

- **NCT ID:** NCT02300753
- **Lead sponsor:** Edison Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300753, "Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02300753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*